World Health Organisation. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organisation; 2018.

Google Scholar 

Boland JW, Bennett MI. State of the science: opioids and survival in cancer pain management. BMJ Support Palliat Care. 2020;10(4):379–80.

Article  PubMed  Google Scholar 

Kotlińska-Lemieszek A, Żylicz Z. Less well-known consequences of the long-term use of opioid analgesics: a comprehensive literature review. Drug Des Devel Ther. 2022;16:251–64.

Article  PubMed  PubMed Central  Google Scholar 

Boland J, Boland E, Brooks D. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone. Clin Med (Lond). 2013;13(2):149–51.

Article  PubMed  PubMed Central  Google Scholar 

Botticelli A, Cirillo A, Pomati G, Cerbelli B, Scagnoli S, Roberto M, et al. The role of opioids in cancer response to immunotherapy. J Transl Med. 2021;19(1):119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medina II WA, Conermann T. Opioid-induced endocrinopathy. 2022 In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing

Raheem OA, Patel SH, Sisul D, Furnish TJ, Hsieh TC. The role of testosterone supplemental therapy in opioid-induced hypogonadism: a retrospective pilot analysis. Am J Mens Health. 2017;11(4):1208–13.

Article  PubMed  Google Scholar 

Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol. 2018;175(14):2726–36.

Article  CAS  PubMed  Google Scholar 

Boland JW. Effect of opioids on survival in patients with cancer. Cancers (Basel). 2022;14(22). Recent comprehensive review of the effect of opioids on survival in patients with cancer.

Boland JW, McWilliams K, Ahmedzai SH, Pockley AG. Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review. Br J Cancer. 2014;111(5):866–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novy DM, Nelson DV, Koyyalagunta D, Cata JP, Gupta P, Gupta K. Pain, opioid therapy, and survival: a needed discussion. Pain. 2020;161(3):496–501.

Article  PubMed  Google Scholar 

Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018;68(3):182–96.

Article  PubMed  PubMed Central  Google Scholar 

Franchi S, Moschetti G, Amodeo G, Sacerdote P. Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies. Front Immunol. 2019;10:2914. A detailed review of the available preclinical and clinical data on the immune effects of different opioids.

Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–25.

Article  CAS  PubMed  Google Scholar 

Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol. 2002;129(1–2):18–24.

Article  CAS  PubMed  Google Scholar 

Martucci C, Panerai AE, Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain. 2004;110(1–2):385–92.

Article  CAS  PubMed  Google Scholar 

Boland JW, Ziegler L, Boland EG, McDermid K, Bennett MI. Is regular systemic opioid analgesia associated with shorter survival in adult patients with cancer? A systematic literature review. Pain. 2015;156(11):2152–63.

Article  CAS  PubMed  Google Scholar 

Zheng J, He J, Wang W, Zhou H, Cai S, Zhu L, et al. The impact of pain and opioids use on survival in cancer patients: results from a population-based cohort study and a meta-analysis. Med. 2020;99(9): e19306.

Article  Google Scholar 

Sathornviriyapong A, Nagaviroj K, Anothaisintawee T. The association between different opioid doses and the survival of advanced cancer patients receiving palliative care. BMC Palliat Care. 2016;15(1):95.

Article  PubMed  PubMed Central  Google Scholar 

Hasegawa T, Oguri T, Osawa T, Sawa T, Osaga S, Okuyama T, et al. Opioid dose and survival of patients with incurable nonsmall cell lung cancer: a prospective cohort study. J Palliat Med. 2018;21(10):1436–41.

Article  PubMed  Google Scholar 

Steele GL, Dudek AZ, Gilmore GE, Richter SA, Olson DA, Eklund JP, et al. Impact of pain, opioids, and the Mu-opioid receptor on progression and survival in patients with newly diagnosed stage IV pancreatic cancer. Am J Clin Oncol. 2020;43(8):591–7.

Article  CAS  PubMed  Google Scholar 

Zylla D, Steele G, Shapiro A, Richter S, Gupta P. Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies. Supp Care Cancer. 2018;26(7):2259–66.

Article  Google Scholar 

Boland JW, Allgar V, Boland EG, Bennett MI, Kaasa S, Hjermstad MJ, et al. The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the International European Palliative Care Cancer Symptom study. Eur J Clin Pharmacol. 2020;76(3):393–402. A recent prospective study looking at clinical outcomes of patients with advanced cancer taking opioids.

Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040–9.

Article  CAS  PubMed  Google Scholar 

Zylberberg HM, Woodrell C, Rustgi SD, Aronson A, Kessel E, Amin S, et al. Opioid prescription is associated with increased survival in older adult patients with pancreatic cancer in the United States: a propensity score analysis. JCO Oncol Pract. 2022;18(5):e659-68.

Article  PubMed  Google Scholar 

Zylla D, Steele G, Gupta P. A systematic review of the impact of pain on overall survival in patients with cancer. Support Care Cancer. 2017;25(5):1687–98.

Article  PubMed  Google Scholar 

Rolston KVI. Infections in cancer patients with solid tumors: a review. Infect Dis Ther. 2017;6(1):69–83.

Article  PubMed  PubMed Central  Google Scholar 

Choi HR, Song IA, Oh TK. Association of opioid use in the week before death among patients with advanced lung cancer having sepsis. Cancer Contr. 2019;26(1):1073274819871326.

Google Scholar 

Shao YJ, Liu WS, Guan BQ, Hao JL, Ji K, Cheng XJ, et al. Contribution of opiate analgesics to the development of infections in advanced cancer patients. Clin J Pain. 2017;33(4):295–9.

Article  PubMed  Google Scholar 

Suzuki M, Sakurada T, Gotoh K, Watanabe S, Satoh N. Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain. Am J Hosp Palliat Care. 2013;30(7):712–6.

Article  PubMed  Google Scholar 

Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(27):3325–45.

Article  PubMed  Google Scholar 

McNeill R, Boland JW, Wilcock A, Sinnarajah A, Currow DC. Non-steroidal anti-inflammatory drugs for pain in hospice/palliative care: an international pharmacovigilance study. BMJ Support Palliat Care. 2023

Edwards HL, Mulvey MR, Bennett MI. Cancer-related neuropathic pain. Cancers (Basel). 2019 16;11(3)

Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29((Suppl 4)):iv166-91.

Article  CAS  PubMed  Google Scholar 

Wood H, Dickman A, Star A, Boland JW. Updates in palliative care - overview and recent advancements in the pharmacological management of cancer pain. Clin Med (Lond). 2018;18(1):17–22.

Article  PubMed  PubMed Central  Google Scholar 

Francesco F, Alice N, Filippo G, Daniela R, Enrico B, Emanuela A. Stress axis in the cancer patient: clinical aspects and management. Endocrines. 2021;2:502–13.

Article  CAS  Google Scholar 

Donegan D. Opioid induced adrenal insufficiency: what is new? Curr Opin Endocrinol Diabetes Obes. 2019;26(3):133–8.

Article  CAS  PubMed  Google Scholar 

Gebauer J, Higham C, Langer T, Denzer C, Brabant G. Long-term endocrine and metabolic consequences of cancer treatment: a systematic review. Endocr Rev. 2019;40(3):711–67.

Article  PubMed  Google Scholar 

Antony T, Alzaharani SY, El-Ghaiesh SH. Opioid-induced hypogonadism: pathophysiology, clinical and therapeutics review. Clin Exp Pharmacol Physiol. 2020;47(5):741–50.

Article  CAS  PubMed  Google Scholar 

Abou-Kassem D, Kurita GP, Sjøgren P, Diasso PDK. Long-term opioid treatment and endocrine measures in patients with cancer-related pain: a systematic review. Scand J Pain. 2022;22(3):421–35. A recent systematic review detailing evidence for opioid-induced endocrinopathies in cancer patients.

Fountas A, Chai ST, Kourkouti C, Karavitaki N. Mechanisms of endocrinology: endocrinology of opioids. Eur J Endocrinol. 2018;179(4):R183-96.

Article  PubMed  Google Scholar 

Salata B, Kluczna A, Dzierżanowski T. 2022 Opioid-induced sexual dysfunction in cancer patients. Cancers (Basel). 14(16)

Esmat Hosseini S, Ilkhani M, Rohani C, NikbakhtNasrabadi A, GhaneiGheshlagh R, Moini A. Prevalence of sexual dysfunction in women with cancer: a systematic review and meta-analysis. Int J Reprod Biomed. 2022;20(1):1–12.

PubMed  PubMed Central  Google Scholar 

Breivik H, Stubhaug A. Endocrinopathies in women during opioid therapy cause loss of androgens, fatigue, listlessness, loss of libido and quality of life: stop prescribing opioids or follow the 2016 Centers for Disease Control and Prevention guidelines? Pain. 2017;158(1):1–3.

Article  PubMed  Google Scholar 

Marudhai S, Patel M, ValaiyaduppuSubas S, Ghani MR, Busa V, Dardeir A, et al. Long-term opioids linked to hypogonadism and the role of testosterone supplementation therapy. Cureus. 2020;12(10): e10813.

PubMed  PubMed Central